Research on China
Monoclonal Antibody (McAB) Industry, 2014 mainly carries on in-depth analysis
on policy environment, global market, Chinese market, as well as the latest
developments of domestic key enterprises related to China's monoclonal antibody
industry.
Several Chinese
large-scale pharmaceutical enterprises devoted themselves to research and
development of monoclonal antibody agents, which have achieved results in 2013.
Hengrui Medicine Co., Ltd., Shanghai Pharmaceuticals Co., Ltd. and Qilu Pharm have
applied for clinical research of monoclonal antibody agents. And Walvax
Biotechnology Co., Ltd even made a huge investment in purchasing Genor
Biopharma Co., Ltd, attempting to establish a large biological strategy.
Although large-scale pharmaceutical enterprises entered monoclonal antibody
field on a large scale, the overall innovation is still insufficient, and the
market is represented by monoclonal antibody agents and biological analogue
that have submitted applications, few imitated drugs, and innovative medicines
are rare and precious things, mainly on account of high risks and long-time
cycle.
Full Report Now
Available For Radiant Insights Customer @ http://www.radiantinsights.com/research/research-on-china-monoclonal-antibody-mcab-industry-2014
Due to late state,
China's strength on research and development will be still vulnerable within
future three to five years, so it has to open the market preliminarily by
depending on generic drugs. In 2013, the market size was CNY 3.8 billion
around, up 30% year-on-year; product categories and sales volume were far less
than that of European and American countries.
According to statistical
data of Shanghai Pharmaceutical Profession Association (SPPA), China will see
four to six monoclonal antibody agents by 2016, such as Trastuzumab and
Rituximab. And it is expected by 2020, six to ten monoclonal antibody agents
will be listed in market, and some of which are independently researched drugs.
Huidian Research believes that China's monoclonal antibody market will embrace
its first climax from 2017 to 2020.
About Radiant Insights
Radiant Insights is a platform for companies looking to meet
their market research and business intelligence requirements. We assist and
facilitate organizations and individuals procure market research reports,
helping them in the decision making process. We have a comprehensive collection
of reports, covering over 40 key industries and a host of micro markets. In
addition to over extensive database of reports, our experienced research
coordinators also offer a host of ancillary services such as, research
partnerships/ tie-ups and customized research solutions.
For More Information Visit – Radiant Insights
Contact:
Michelle Thoras
Corporate Sales Specialist, USA
Radiant Insights, Inc
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@radiantinsights.com
No comments:
Post a Comment